Submissions from 2019
Comprehensive Genomic Tumor Profiling, Brian D. Piening
Glioblastoma Mimicking Viral Encephalitis Responds to Acyclovir: A Case Series and Literature Review., Keenan J Piper, Haidn Foster, Brandon Gabel, Burt Nabors, and Charles Cobbs
Blockade of TGF-β signaling to enhance the antitumor response is accompanied by dysregulation of the functional activity of CD4, Magdalena J Polanczyk, Edwin Walker, Daniel Haley, Bella S Guerrouahen, and Emmanuel T Akporiaye
A Pan-Cancer Approach to Predict Responsiveness to Immune Checkpoint Inhibitors by Machine Learning., Maurizio Polano, Marco Chierici, Michele Dal Bo, Davide Gentilini, Federica Di Cintio, Lorena Baboci, David L Gibbs, Cesare Furlanello, and Giuseppe Toffoli
OX40 Agonist Tumor Immunotherapy Does Not Impact Regulatory T Cell Suppressive Function., Fanny Polesso, Minhaz Sarker, Andrew D Weinberg, Susan E Murray, and Amy E Moran
OX40 Agonist Tumor Immunotherapy Does Not Impact Regulatory T Cell Suppressive Function., Fanny Polesso, Minhaz Sarker, Andrew D Weinberg, Susan E Murray, and Amy E Moran
Recurrence After Robotic Retroperitoneal Lymph Node Dissection Raises More Questions than Answers., James R Porter, Scott Eggener, Erik Castle, and Phillip Pierorazio
Regeneration Enhances Metastasis: A Novel Role for Neurovascular Signaling in Promoting Melanoma Brain Metastasis., Roshini Prakash, Sivan Izraely, Nikita S Thareja, Rex H Lee, Maya Rappaport, Riki Kawaguchi, Orit Sagi-Assif, Shlomit Ben-Menachem, Tsipi Meshel, Michal Machnicki, Shuichi Ohe, Dave S B Hoon, Giovanni Coppola, Isaac P Witz, and S Thomas Carmichael
Immunological Complexity of the Prostate Cancer Microenvironment Influences the Response to Immunotherapy., Nataliya Prokhnevska, Dana A Emerson, Haydn T Kissick, and William L. Redmond
Upregulation of Ganglioside GD3 Synthase (ST8SIA1) Promotes Distant Organ Metastasis In Melanoma Patients, Irene Ramos
Renal Considerations in the Oncology Patient, Sridhar K. Reddy
Non-TB Mycobacterial Infection-Bronchiectasis Nexus., Jerome M Reich
Non-TB Mycobacterial Infection-Bronchiectasis Nexus., Jerome M Reich
Two Radiographic Features Favoring Radiation Pneumonitis in the Differential Diagnosis., Jerome M Reich
Current Controversies in Cardiothoracic Imaging: Low-dose Computerized Tomographic Overdiagnosis of Lung Cancer is Substantial; Its Consequences are Underappreciated-Point., Jerome M Reich and Jong S Kim
Earlier Diagnosis Not Self-Evidently Beneficial: Natural History of Subcentimeter Lung Cancers., Jerome M Reich and Jong S Kim
Birds of a Feather? Genetic Counseling, Genetic Testing, and Humanism., Robert Resta
INTRODUCTION TO EXPLORING THE EXOME SPECIAL ISSUE., Robert Resta, Jennifer Sullivan, and Allyn McConkie-Rosell
Provider Attitudes and Practice Patterns for Direct-Acting Antiviral Therapy for Patients with Hepatocellular Carcinoma., Nicole E Rich, Ju Dong Yang, Ponni V Perumalswami, Naim Alkhouri, Whitney Jackson, Neehar D Parikh, Neil Mehta, Reena Salgia, Andres Duarte-Rojo, Laura Kulik, Mina Rakoski, Adnan Said, Omobonike Oloruntoba, George N Ioannou, Maarouf A Hoteit, Andrew M Moon, Amol S Rangnekar, Sheila L Eswaran, Elizabeth Zheng, Janice H Jou, James Hanje, Anjana Pillai, Ruben Hernaez, Robert Wong, Steven Scaglione, Hrishikesh Samant, Devika Kapuria, Shaun Chandna, Russell Rosenblatt, Veeral Ajmera, Catherine Frenette, Sanjaya K Satapathy, Parvez Mantry, Prasun Jalal, Binu V John, Oren K Fix, Michael Leise, Christina C Lindenmeyer, Avegail Flores, Nayan Patel, Z Gordon Jiang, Nyan Latt, Renumathy Dhanasekaran, Mobolaji Odewole, Sofia Kagan, Jorge A Marrero, and Amit G Singal
Phase Ib with expansion study of olaparib plus weekly (Metronomic) carboplatin and paclitaxel in relapsed ovarian cancer patients., Saul Eugene Rivkin, James Moon, Desiree S Iriarte, Erik Bailey, Heather L Sloan, Gary E Goodman, Amy E BonDurant, Dan Velijovich, Tanya Wahl, Peter Jiang, Chirag A Shah, Charles Drescher, MF Fer, Henry G Kaplan, and Erin D Ellis
Tumor Lysis, Adverse Events, and Dose Adjustments in 297 Venetoclax-Treated CLL Patient in Routine Clinical Practice., Lindsey E Roeker, Christopher P Fox, Toby A Eyre, Danielle M Brander, John N Allan, Stephen J Schuster, Chadi Nabhan, Brian T Hill, Nirav N Shah, Frederick Lansigan, Maryam Yazdy, Bruce D Cheson, Nicole Lamanna, Arun K Singavi, Catherine C Coombs, Paul M Barr, Alan P Skarbnik, Mazyar Shadman, Chaitra S Ujjani, Hande H Tuncer, Allison M Winter, Joanna Rhodes, Colleen Dorsey, Hannah Morse, Charlene Kabel, John M Pagel, Annalynn M Williams, Ryan Jacobs, Andre Goy, Sivraj Muralikrishnan, Laurie Pearson, Andrea Sitlinger, Neil Bailey, Anna Schuh, Amy A Kirkwood, and Anthony R Mato
Nomogram for Predicting Individual Survival After Recurrence of Advanced-Stage, High-Grade Ovarian Carcinoma., Peter G Rose, James J Java, Ritu Salani, Melissa A Geller, Angeles Alvarez Secord, Krishnansu S Tewari, David P Bender, David G Mutch, Michael L Friedlander, Linda Van Le, Michael W Method, Chad A Hamilton, Roger B Lee, Robert M Wenham, Saketh R Guntupalli, Maurie Markman, Franco M Muggia, Deborah K Armstrong, Michael A Bookman, Robert A Burger, and Larry J Copeland
Cervical cancer in Tanzania: A systematic review of current challenges in six domains., Ava S Runge, Megan E Bernstein, Alexa N Lucas, and Krishnansu S Tewari
Immunotherapy Toxicities., Katherine Sanchez, David B Page, and Walter Urba
Phase I/II trial of nano-camptothecin CRLX101 with capecitabine and radiotherapy as neoadjuvant treatment for locally advanced rectal cancer., Hanna K Sanoff, Dominic H Moon, Dominic T Moore, Jeremiah Boles, Courtney Bui, William Blackstock, Bert H O'Neil, Somasundaram Subramaniam, Autumn J McRee, Cheryl Carlson, Michael S Lee, Joel E Tepper, and Andrew Z Wang
ASO Author Reflections: The Changing Landscape for Industry Support to Surgical Oncologists., Juan A Santamaria-Barria and Anton J Bilchik
Changing Trends in Industry Funding for Surgical Oncologists., Juan A Santamaria-Barria, Stacey L Stern, Adam Khader, Mary Garland-Kledzik, Anthony J Scholer, Trevan D Fischer, and Anton J Bilchik
Hospitalized patients quantify verbal pain intensity descriptors: methodological issues and values for 26 descriptors., Judith M Schlaeger, Kevin C Cain, Erin K Myklebust, Keesha L Powell-Roach, Brenda W Dyal, and Diana J Wilkie
Developing "Nurse AMIE": A tablet-based supportive care intervention for women with metastatic breast cancer., Kathryn H Schmitz, Xiaochen Zhang, Renate Winkels, Erica Schleicher, Katlynn Mathis, Shawna Doerksen, Leah Cream, Jennifer Rosenberg, Rena Kass, Michelle Farnan, Patricia Halpin-Murphy, Robin Suess, David S Zucker, and Michael Hayes
Downregulation of CENPF Remodels Prostate Cancer Cells and Alters Cellular Metabolism., Muhammad Shahid, Minhyung Kim, Min Young Lee, Austin Yeon, Sungyong You, Hyung L Kim, and Jayoung Kim
Glioblastoma: Biology, Diagnosis, and Treatment, Akanksha Sharma, Maciej M. Mrugala, and Jan Buckner
ELEVATE TN: Phase 3 Study of Acalabrutinib Combined with Obinutuzumab (O) or Alone Vs O Plus Chlorambucil (Clb) in Patients (Pts) with Treatment-Naive Chronic Lymphocytic Leukemia (CLL)., Jeff P Sharman, Versha Banerji, Laura Maria Fogliatto, Yair Herishanu, Talha Munir, Renata Walewska, George Follows, Karin Karlsson, Paolo Ghia, Gillian Corbett, Patricia Walker, Miklos Egyed, Wojciech Jurczak, Gilles Salles, Ann Janssens, Florence Cymbalista, William G Wierda, Steven Coutre, John M Pagel, Alan Skarbnik, Manali Kamdar, Jennifer Woyach, Raquel Izumi, Veerendra Munugalavadla, Priti Patel, Min Hui Wang, Sofia Wong, and John C Byrd
Final Results of a Randomized, Phase III Study of Rituximab With or Without Idelalisib Followed by Open-Label Idelalisib in Patients With Relapsed Chronic Lymphocytic Leukemia., Jeff P Sharman, Steven E Coutre, Richard R Furman, Bruce D Cheson, John M Pagel, Peter Hillmen, Jacqueline C Barrientos, Andrew D Zelenetz, Thomas J Kipps, Ian W Flinn, Paolo Ghia, Herbert Eradat, Thomas Ervin, Nicole Lamanna, Bertrand Coiffier, Andrew R Pettitt, Shuo Ma, Eugen Tausch, Paula Cramer, Julie Huang, Siddhartha Mitra, Michael Hallek, Susan M O'Brien, and Stephan Stilgenbauer
Melanoma Within Basal Cell Carcinoma Nests Discovered During Mohs Micrographic Surgery., Christine M Shaver, Steven E Kolker, and Richard G Bennett
Body Mass Index (BMI), BMI Change, and Overall Survival in Patients With SCLC and NSCLC: A Pooled Analysis of the International Lung Cancer Consortium., Daniel Shepshelovich, Wei Xu, Lin Lu, Aline Fares, Ping Yang, David Christiani, Jie Zhang, Kouya Shiraishi, Brid M Ryan, Chu Chen, Ann G Schwartz, Adonina Tardon, Xifeng Wu, Matthew B Schabath, M Dawn Teare, Loic Le Marchand, Zuo-Feng Zhang, John K Field, Hermann Brenner, Nancy Diao, Juntao Xie, Takashi Kohno, Curtis C Harris, Angela S Wenzlaff, Guillermo Fernandez-Tardon, Yuanqing Ye, Fiona Taylor, Lynne R Wilkens, Michael Davies, Yi Liu, Matt J Barnett, Gary E Goodman, Hal Morgenstern, Bernd Holleczek, M Catherine Brown, Geoffrey Liu, and Rayjean Hung
Trifluridine/tipiracil (FTD/TPI) in patients (pts) aged ≥65 years with metastatic gastric/gastroesophageal junction cancer (mGC/mGEJC): Subgroup analysis from TAGS., Kohei Shitara, Toshihiko Doi, Hisashi Hosaka, Peter C. Thuss-Patience, Armando Santoro, Paula Jiménez-Fonseca, Federico Longo, Ozgur Ozyilkan, Irfan Cicin, David Park, Mohamedtaki Abdulaziz Tejani, Aziz Zaanan, Domenico Bilancia, Carles Pericay, Mustafa Ozguroglu, Maria Alsina, Lukas Makris, Sandra McGuigan, and David H. Ilson
High-Dose Ipilimumab and High-Dose Interleukin-2 for Patients With Advanced Melanoma., Ann W Silk, Howard L Kaufman, Brendan Curti, Janice M Mehnert, Kim Margolin, David McDermott, Joseph Clark, Jenna Newman, Praveen K Bommareddy, Lisa Denzin, Saltanat Najmi, Azra Haider, Weichung Shih, Michael P Kane, and Andrew Zloza
Oncoplastic Breast Surgery: From Oblivion to Mainstream., Melvin J Silverstein
The Breast Centers That Almost Never Were., Melvin J Silverstein
Immunotherapy for Head and Neck Cancer., Felix Sim, Rom Leidner, and Richard Bryan Bell
Immunotherapy for Head and Neck Cancer., Felix Sim, Rom Leidner, and Richard Bryan Bell
Immunotherapy for Head and Neck Cancer., Felix Sim, Rom Leidner, and Richard Bryan Bell
Primary Cardiac Sarcoma: A Rare, Aggressive Malignancy with a High Propensity for Brain Metastases., Brittany L Siontis, Lili Zhao, Monika Leja, Jonathan B McHugh, Maryann M Shango, Laurence H Baker, Scott M Schuetze, and Rashmi Chugh
Painting a portrait: Analysis of national health survey data for cancer genetic counseling., Monica H Stamp, Ora K Gordon, Christopher P Childers, and Kimberly K Childers
Major pathologic response on biopsy (MPRbx) in patients with advanced melanoma treated with anti-PD-1: evidence for an early, on-therapy biomarker of response., J E Stein, A Soni, L Danilova, T R Cottrell, T F Gajewski, F S Hodi, S Bhatia, W J Urba, W H Sharfman, M Wind-Rotolo, R Edwards, E J Lipson, and J M Taube
A multi-institutional analysis of 263 hilar tumors during robot-assisted partial nephrectomy., Peter L Sunaryo, David J Paulucci, Kennedy Okhawere, Alp Tuna Beksac, John P Sfakianos, Ronney Abaza, Daniel D Eun, Akshay Bhandari, Ashok K Hemal, James R Porter, and Ketan K Badani
Subcellular compartmentalization of PKM2 identifies anti-PKM2 therapy response in vitro and in vivo mouse model of human non-small-cell lung cancer., Akiko Suzuki, Sachin Puri, Pamela Leland, Ankit Puri, Tarsem Moudgil, Bernard A Fox, Raj K Puri, and Bharat H Joshi
Colon cancer as a subsequent malignant neoplasm in young adults., Annabelle Teng, Daniel Nelson, Ahmed N Dehal, Shu-Ching Chang, Trevan D Fischer, Scott R Steele, and Melanie Goldfarb
Implications of Prolonged Time to Pancreaticoduodenectomy After Neoadjuvant Chemoradiation., Annabelle Teng, Trang Nguyen, Anton J Bilchik, Victoria O'Connor, and David Y Lee
Pediatric gastric adenocarcinoma: A National Cancer Data Base review., Robert A Tessler, Matthew Dellinger, Morgan K Richards, Adam B Goldin, Elizabeth A Beierle, John J Doski, Melanie Goldfarb, Monica Langer, Jed G Nuchtern, Mehul V Raval, Sanjeev Vasudevan, and Kenneth W Gow
Immune Checkpoint Blockade in PD-L1-Positive Platinum-Refractory Cervical Carcinoma., Krishnansu S Tewari
Recurrence of Melanoma After a Negative Sentinel Node Biopsy: Predictors and Impact of Recurrence Site on Survival., Daniel C Thomas, Gang Han, Stanley P Leong, Mohammed Kashani-Sabet, John Vetto, Barbara Pockaj, Richard L White, Mark B Faries, Schlomo Schneebaum, Nicola Mozzillo, Kim J Charney, Vernon K Sondak, Jane L Messina, Jonathan S Zager, and Dale Han
Recurrence of Melanoma After a Negative Sentinel Node Biopsy: Predictors and Impact of Recurrence Site on Survival., Daniel C Thomas, Gang Han, Stanley P Leong, Mohammed Kashani-Sabet, John Vetto, Barbara Pockaj, Richard L White, Mark B Faries, Schlomo Schneebaum, Nicola Mozzillo, Kim J Charney, Vernon K Sondak, Jane L Messina, Jonathan S Zager, and Dale Han
Preoperative Ultrasound Assessment of Regional Lymph Nodes in Melanoma Patients Does not Provide Reliable Nodal Staging: Results from a Large Multicenter Trial., John F Thompson, Lauren E Haydu, Roger F Uren, Robert H Andtbacka, Jonathan S Zager, Peter D Beitsch, Doreen M Agnese, Nicola Mozzillo, Alessandro Testori, Tawnya L Bowles, Harald J Hoekstra, Mark C Kelley, Jeffrey Sussman, Schlomo Schneebaum, B Mark Smithers, Gregory McKinnon, Eddy Hsueh, Lisa Jacobs, Erwin Schultz, Douglas Reintgen, John M Kane, Erica B Friedman, Hejing Wang, Lisa Van Kreuningen, Vicki Schiller, David A Elashoff, Robert Elashoff, Alistair J Cochran, Stacey Stern, and Mark B Faries
Mild Cognitive Deficits from Cancer Treatments, Jason Tse
Development and Pilot Testing of an Assessment Tool for Performance of Invasive Mediastinal Staging., Simon R Turner, Basil S Nasir, Hollis Lai, Kazuhiro Yasufuku, Colin Schieman, Brian E Louie, and Eric Lr Bédard
The Immune Microenvironment Impacts Survival in Western Patients with Gastric Adenocarcinoma., Abhineet Uppal, Ahmed N Dehal, Shu-Ching Chang, Dany Barrak, Yalda Naeini, John R Jalas, and Anton J Bilchik
Regional Node Basin Recurrence in Melanoma Patients: More Common After Node Dissection for Macroscopic Rather than Clinically Occult Nodal Disease., Abhineet Uppal, Stacey L Stern, John F Thompson, Leland J Foshag, Nicola Mizzollo, Omgo E Nieweg, Harald J Hoekstra, Daniel F Roses, Vernon K Sondak, Mohammed Kashani-Sabet, Brendon J Coventry, Alistair J Cochran, Manabu Fujita, Myung Sim-Shin, David Elashoff, Robert M Elashoff, and Mark B Faries
Duodenal GI stromal tumors: Is radical resection necessary?, Abhineet Uppal, Mansen Wang, Trevan D Fischer, and Melanie Goldfarb
Yttrium-90-labeled anti-CD45 antibody followed by a reduced-intensity hematopoietic cell transplantation for patients with relapsed/refractory leukemia or myelodysplasia., Phuong Vo, Ted A Gooley, Joseph G Rajendran, Darrell R Fisher, Johnnie J Orozco, Damian J Green, Ajay K Gopal, Robyn Haaf, Margaret Nartea, Rainer Storb, Frederick R Appelbaum, Oliver W Press, John M Pagel, and Brenda M Sandmaier
A Simple Measure of Hepatocellular Carcinoma Burden Predicts Tumor Recurrence after Liver Transplantation: The RH-IML Classification., Philip Vutien, Jennifer Dodge, Kiran M Bambha, Eric M Nordstrom, Jane Gralla, Kristen Campbell, Claire Levek, Trevor Nydam, Oren Fix, George Ioannou, and Scott W Biggins
A Simple Measure of Hepatocellular Carcinoma Burden Predicts Tumor Recurrence After Liver Transplantation: The Recurrent Hepatocellular Carcinoma-Initial, Maximum, Last Classification., Philip Vutien, Jennifer Dodge, Kiran M Bambha, Eric M Nordstrom, Jane Gralla, Kristen Campbell, Claire Levek, Trevor Nydam, Oren K Fix, George Ioannou, and Scott W Biggins
The Cancer Immunotherapy Biomarker Testing Landscape., Eric E Walk, Sophia L Yohe, Amy Beckman, Andrew Schade, Mary M Zutter, John Pfeifer, and Anna B Berry
Phase 1 Trial of Fruquintinib in Patients with Advanced Solid Tumors: Results of the Dose Escalation Phase., A Wang-Gillam, H Park, H Yeckes-Rodin, Thomas Stanton, M Kosmo, S Fan, N Sauter, and M Kanie
Programmed Cell Death Receptor (PD-1) Ligand (PD-L1) expression in Philadelphia chromosome-negative myeloproliferative neoplasms., Jen-Chin Wang, Chi Chen, Ajay Kundra, Sreenath Kodali, Anita Pandey, Ching Wong, Tony Cheung, Vladimir Gotlieb, Gardith Joseph, and Sophia Tribie
Pancreatic islet cell tumors in adolescents and young adults., Alicia M Waters, Ilan I Maizlin, Robert T Russell, Matthew Dellinger, Kenneth W Gow, Adam Goldin, Melanie Goldfarb, Jed G Nuchtern, Monica Langer, Sanjeev A Vasudevan, John J Doski, Mehul Raval, and Elizabeth A Beierle
Prevalence of trismus in patients with head and neck cancer: A systematic review with meta-analysis., Amber L Watters, Shane Cope, Meir N Keller, Mariela Padilla, and Reyes Enciso
Special Issue on Single-Cell Multiomics for Immuno-Oncology and Cancer Systems Biology., Wei Wei and Rong Fan
A Randomized Double-Blind Placebo-Controlled Phase 2 Trial Of Dendritic Cell Vaccine ICT-107 In Newly Diagnosed Patients With Glioblastoma., Patrick Y Wen, David A Reardon, Terri S Armstrong, Surasak Phuphanich, Robert D Aiken, Joseph C Landolfi, William T Curry, Jay-Jiguang Zhu, Michael Glantz, David M Peereboom, James Markert, Renato LaRocca, Donald M O'Rourke, Karen Fink, Lyndon Kim, Michael Gruber, Glenn J Lesser, Edward Pan, Santosh Kesari, Alona Muzikansky, Clemencia Pinilla, Radleigh G Santos, and John S Yu
Buparlisib in Patients With Recurrent Glioblastoma Harboring Phosphatidylinositol 3-Kinase Pathway Activation: An Open-Label, Multicenter, Multi-Arm, Phase II Trial., Patrick Y Wen, Mehdi Touat, Brian M Alexander, Ingo K Mellinghoff, Shakti Ramkissoon, Christine S McCluskey, Kristine Pelton, Sam Haidar, Sankha S Basu, Sarah C Gaffey, Loreal E Brown, Juan Emmanuel Martinez-Ledesma, Shaofang Wu, Jungwoo Kim, Wei Wei, Mi-Ae Park, Jason T Huse, John G Kuhn, Mikael L Rinne, Howard Colman, Nathalie Y R Agar, Antonio M Omuro, Lisa M DeAngelis, Mark R Gilbert, John F de Groot, Timothy F Cloughesy, Andrew S Chi, Thomas M Roberts, Jean J Zhao, Eudocia Q Lee, Lakshmi Nayak, James R Heath, Laura L Horky, Tracy T Batchelor, Rameen Beroukhim, Susan M Chang, Azra H Ligon, Ian F Dunn, Dimpy Koul, Geoffrey S Young, Michael D Prados, David A Reardon, W K Alfred Yung, and Keith L Ligon
Buparlisib in Patients With Recurrent Glioblastoma Harboring Phosphatidylinositol 3-Kinase Pathway Activation: An Open-Label, Multicenter, Multi-Arm, Phase II Trial., Patrick Y Wen, Mehdi Touat, Brian M Alexander, Ingo K Mellinghoff, Shakti Ramkissoon, Christine S McCluskey, Kristine Pelton, Sam Haidar, Sankha S Basu, Sarah C Gaffey, Loreal E Brown, Juan Emmanuel Martinez-Ledesma, Shaofang Wu, Jungwoo Kim, Wei Wei, Mi-Ae Park, Jason T Huse, John G Kuhn, Mikael L Rinne, Howard Colman, Nathalie Y R Agar, Antonio M Omuro, Lisa M DeAngelis, Mark R Gilbert, John F de Groot, Timothy F Cloughesy, Andrew S Chi, Thomas M Roberts, Jean J Zhao, Eudocia Q Lee, Lakshmi Nayak, James R Heath, Laura L Horky, Tracy T Batchelor, Rameen Beroukhim, Susan M Chang, Azra H Ligon, Ian F Dunn, Dimpy Koul, Geoffrey S Young, Michael D Prados, David A Reardon, W K Alfred Yung, and Keith L Ligon
Atezolizumab in combination with carboplatin plus nab-paclitaxel chemotherapy compared with chemotherapy alone as first-line treatment for metastatic non-squamous non-small-cell lung cancer (IMpower130): a multicentre, randomised, open-label, phase 3 trial., Howard J. West, Michael McCleod, Maen Hussein, Alessandro Morabito, Achim Rittmeyer, Henry J Conter, Hans-Georg Kopp, Davey Daniel, Steven McCune, Tarek Mekhail, Alona Zer, Niels Reinmuth, Ahad Sadiq, Alan Sandler, Wei Lin, Tania Ochi Lohmann, Venice Archer, Lijia Wang, Marcin Kowanetz, and Federico Cappuzzo
Navigation’s Impact on Clinical Trial Participation in Cancer Research: Barriers, Evidence, and Strategies, Claire White, Laura Hynes, Lucy J. Gansauer, Mary Van Cleave, Lavinia Dobrea, Amy Meleason, and Daniel McGough
Multispectral Fluorescence Imaging Allows for Distinctive Topographic Assessment and Subclassification of Tumor-Infiltrating and Surrounding Immune Cells., Claudia Wickenhauser, Daniel Bethmann, Zipei Feng, Shawn M. Jensen, Carmen Ballesteros-Merino, Chiara Massa, Andre Steven, Marcus Bauer, Peter Kaatzsch, Nikolaos Pazaitis, Georgiana Toma, Carlo Bifulco, Bernard A Fox, and Barbara Seliger
Recurrence rates for patients with early-stage breast cancer treated with IOERT at a community hospital per the ASTRO consensus statement for APBI., Venita L Williams, Tanuja Bhandari, Lillian J Chen, Lawrence D Wagman, Michele Carpenter, Jay K Harness, Rajesh Khanijou, Maher Gobran, Windy Olaya, Melissa I Carandang, and Robert B Ash
Expression and effects of leukemia inhibitory factor on nucleus pulposus degeneration., Qiang Xiao, Ji-Huan Zeng, Hao Zhou, Quan-He Qiu, Bo Ke, Liang Deng, Zhen-Ming Hu, Jeffrey Roh, and Min Dai
Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy., Ke Xu, Dongkyoo Park, Andrew T Magis, Jun Zhang, Wei Zhou, Gabriel L Sica, Suresh S Ramalingam, Walter J Curran, and Xingming Deng
Repurposed Drugs in Treating Glioblastoma Multiforme: Clinical Trials Update., S Yadavalli, V M Yenugonda, and S Kesari
Activation of Wnt signaling promotes olaparib resistant ovarian cancer., Tomomi M Yamamoto, Alexandra McMellen, Zachary L Watson, Jennifer Aguilera, Rebecca Ferguson, Elmar Nurmemmedov, Tanay Thakar, George-Lucian Moldovan, Hyunmin Kim, Diana M Cittelly, Annette M Joglar, Elyse P Brennecke, Heidi Wilson, Kian Behbakht, Matthew J Sikora, and Benjamin G Bitler
Toxicities and Outcomes of Acalabrutinib-Treated Patients with Chronic Lymphocytic Leukemia: A Retrospective Analysis of Real World Patients, Maryam Sarraf Yazdy, John M Pagel, Neil Bailey, Krish Patel, and See full list of authors in comments
How Many Nodes Need to be Removed to Make Esophagectomy an Adequate Cancer Operation, and Does the Number Change When a Patient has Chemoradiotherapy Before Surgery?, Jonathan C Yeung, Manjit S Bains, Arianna Barbetta, Tamar Nobel, Steven R DeMeester, Brian E Louie, Mark B Orringer, Linda W Martin, Rishindra M Reddy, Francisco Schlottmann, and Daniela Molena
Daratumumab, bortezomib, cyclophosphamide and dexamethasone in newly diagnosed and relapsed multiple myeloma: LYRA study., Habte Yimer, Jason Melear, Edward Faber, William Bensinger, John M Burke, Mohit Narang, Don Stevens, Sriya Gunawardena, Yana Lutska, Keqin Qi, Jon Ukropec, Ming Qi, Thomas S Lin, and Robert M Rifkin
Daratumumab, bortezomib, cyclophosphamide and dexamethasone in newly diagnosed and relapsed multiple myeloma: LYRA study., Habte Yimer, Jason Melear, Edward Faber, William Bensinger, John M Burke, Mohit Narang, Don Stevens, Sriya Gunawardena, Yana Lutska, Keqin Qi, Jon Ukropec, Ming Qi, Thomas S Lin, and Robert M Rifkin
A systems approach to clinical oncology uses deep phenotyping to deliver personalized care., James T Yurkovich, Qiang Tian, Nathan D Price, and Leroy Hood
A microbial-based cancer vaccine for induction of EGFRvIII-specific CD8+ T cells and anti-tumor immunity., Lauren Zebertavage, Shelly Bambina, Jessica Shugart, Alejandro Alice, Kyra D Zens, Peter Lauer, Bill Hanson, Michael J. Gough, Marka R Crittenden, and Keith S Bahjat
STAT3 Activation-Induced Fatty Acid Oxidation in CD8, Chunyan Zhang, Chanyu Yue, Andreas Herrmann, Jieun Song, Colt Egelston, Tianyi Wang, Zhifang Zhang, Wenzhao Li, Heehyoung Lee, Maryam Aftabizadeh, Yi Jia Li, Peter P Lee, Stephen Forman, George Somlo, Peiguo Chu, Laura Kruper, Joanne Mortimer, Dave S B Hoon, Wendong Huang, Saul Priceman, and Hua Yu
Somatostatin Receptor Ligand Therapy-A Novel Therapy for Neurocytoma., Dongyun Zhang, Sarah S R Kim, Daniel F Kelly, Sylvia L Asa, Masoud Movassaghi, Sergey Mareninov, William H Yong, Timothy F Cloughesy, Fausto J Rodriguez, Paul McKeever, Jiang Qian, Jian Yi Li, Qinwen Mao, Kathy L Newell, Richard M Green, Cynthia T Welsh, Zhenggang Xiong, and Anthony P Heaney
Somatostatin Receptor Ligand Therapy-A Potential Therapy for Neurocytoma., Dongyun Zhang, Sarah S R Kim, Daniel F Kelly, Sylvia L Asa, Masoud Movassaghi, Sergey Mareninov, William H Yong, Timothy F Cloughesy, Fausto J Rodriguez, Paul McKeever, Jiang Qian, Jian Yi Li, Qinwen Mao, Kathy L Newell, Richard M Green, Cynthia T Welsh, Zhenggang Xiong, and Anthony P Heaney
B7H3 regulates differentiation and serves as a potential biomarker and theranostic target for human glioblastoma., Jingwen Zhang, Jinhua Wang, Diego M Marzese, Xiaowen Wang, Zixiao Yang, Chunjie Li, Haibo Zhang, Jinsen Zhang, Clark C Chen, Daniel F Kelly, Wei Hua, Dave S B Hoon, and Ying Mao
Survivin is a prognostic marker and therapeutic target for extranodal, nasal-type natural killer/T cell lymphoma., Li Zhang, Yi Wei, Xiaowei Yan, Na Li, Haolan Song, Li Yang, Yang Wu, Yu-Feng Xi, Hua-Wei Weng, Jian-Hua Li, Edward H Lin, and Li-Qun Zou
Longitudinal multi-omics of host-microbe dynamics in prediabetes., Wenyu Zhou, M Reza Sailani, Kévin Contrepois, Yanjiao Zhou, Sara Ahadi, Shana R Leopold, Martin J Zhang, Varsha Rao, Monika Avina, Tejaswini Mishra, Jethro Johnson, Brittany Lee-McMullen, Songjie Chen, Ahmed A Metwally, Thi Dong Binh Tran, Hoan Nguyen, Xin Zhou, Brandon Albright, Bo-Young Hong, Lauren Petersen, Eddy Bautista, Blake Hanson, Lei Chen, Daniel Spakowicz, Amir Bahmani, Denis Salins, Benjamin Leopold, Melanie Ashland, Orit Dagan-Rosenfeld, Shannon Rego, Patricia Limcaoco, Elizabeth Colbert, Candice Allister, Dalia Perelman, Colleen Craig, Eric Wei, Hassan Chaib, Daniel Hornburg, Jessilyn Dunn, Liang Liang, Sophia Miryam Schüssler-Fiorenza Rose, Kim Kukurba, Brian D. Piening, Hannes Rost, David Tse, Tracey McLaughlin, Erica Sodergren, George M Weinstock, and Michael Snyder
Submissions from 2018
Clear cell carcinoma of the pelvic side wall arising from endometriosis., Lisa N Abaid, John S Cupp, Miles Chang, Steven R Beanes, and Bram H Goldstein
Intratumoral Delivery of MDNA55, an Interleukin-4 Receptor Targeted Immunotherapy, by MRI-Guided Convective Delivery for the Treatment of Recurrent Glioblastoma, Achal Achrol, Manish Aghi, Krystof Bankiewicz, Martin Bexon, Sotirios Bisdas, Steven Brem, Andrew Brenner, Nicholas Butowski, Melissa Coello, Seunggu Jude Han, Santosh Kesari, Fahar Merchant, Dina Randazzo, Diana Roettger, Michael Vogelbaum, Frank Vrionis, Miroslaw Zabek, and John Sampson
A phase II study of frontline paclitaxel/carboplatin/bevacizumab, paclitaxel/carboplatin/temsirolimus, or ixabepilone/carboplatin/bevacizumab in advanced/recurrent endometrial cancer., Carol Aghajanian, Virginia Filiaci, Don S Dizon, Jay W Carlson, Matthew A Powell, Angeles Alvarez Secord, Krishnansu S Tewari, David P Bender, David M O'Malley, Ashley Stuckey, JianJiong Gao, Fanny Dao, Robert A Soslow, Heather A Lankes, Kathleen Moore, and Douglas A Levine
Unintended consequences of decreased PSA-based prostate cancer screening., Thomas Ahlering, Linda My Huynh, Kamaljot S Kaler, Stephen Williams, Kathryn Osann, Jean Joseph, David Lee, John W Davis, Ronney Abaza, Jihad Kaouk, Vipul Patel, Isaac Yi Kim, James Porter, and Jim C Hu
Clinical Development of Novel Drug-Radiotherapy Combinations., Saif S Ahmad, Marka R Crittenden, Phuoc T Tran, Paul G Kluetz, Gideon M Blumenthal, Helen Bulbeck, Richard D Baird, Kaye J Williams, Tim Illidge, Stephen M Hahn, Theodore S Lawrence, Patricia A Spears, Amanda J Walker, and Ricky A Sharma
Amplifying IFN-γ Signaling in Dendritic Cells by CD11c-Specific Loss of SOCS1 Increases Innate Immunity to Infection while Decreasing Adaptive Immunity., Alejandro F Alice, Gwen Kramer, Shelly Bambina, Jason R Baird, Keith S Bahjat, Michael J Gough, and Marka R Crittenden
Perspectives in immunotherapy: meeting report from the Immunotherapy Bridge (29-30 November, 2017, Naples, Italy)., Paolo A Ascierto, James Brugarolas, Luigi Buonaguro, Lisa H Butterfield, David Carbone, Bruno Daniele, Robert Ferris, Bernard A Fox, Jérôme Galon, Cesare Gridelli, Howard L Kaufman, Christopher A Klebanoff, Ignacio Melero, Paul Nathan, Chrystal M Paulos, Marco Ruella, Ryan Sullivan, Hassane Zarour, and Igor Puzanov
